Concepedia

Publication | Open Access

Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy

50

Citations

27

References

2018

Year

Abstract

ICAM/DEX/NLCs may represent a potential pulmonary endothelium targeted device, which facilitate translation of DEX into clinical ALI treatment.

References

YearCitations

2010

2.5K

2007

761

2005

590

2012

158

2016

139

2017

124

2013

106

2012

105

2013

102

2014

89

Page 1